ID29858A - Uji diagnostik tuberkulosis - Google Patents

Uji diagnostik tuberkulosis

Info

Publication number
ID29858A
ID29858A IDW00200100974A ID20010974A ID29858A ID 29858 A ID29858 A ID 29858A ID W00200100974 A IDW00200100974 A ID W00200100974A ID 20010974 A ID20010974 A ID 20010974A ID 29858 A ID29858 A ID 29858A
Authority
ID
Indonesia
Prior art keywords
peptides
diagnostic test
cells
tuberculosis diagnostic
analogues
Prior art date
Application number
IDW00200100974A
Other languages
English (en)
Indonesian (id)
Inventor
Ajit Lalvani
Ansar A Pathan
Original Assignee
Isis Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26314614&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID29858(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9824213.4A external-priority patent/GB9824213D0/en
Application filed by Isis Innovation filed Critical Isis Innovation
Publication of ID29858A publication Critical patent/ID29858A/id

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IDW00200100974A 1998-11-04 1999-11-03 Uji diagnostik tuberkulosis ID29858A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10700498P 1998-11-04 1998-11-04
GBGB9824213.4A GB9824213D0 (en) 1998-11-04 1998-11-04 Diagnostic test

Publications (1)

Publication Number Publication Date
ID29858A true ID29858A (id) 2001-10-18

Family

ID=26314614

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200100974A ID29858A (id) 1998-11-04 1999-11-03 Uji diagnostik tuberkulosis

Country Status (14)

Country Link
US (5) US7632646B1 (de)
EP (1) EP1144447B1 (de)
JP (1) JP4633931B2 (de)
CN (1) CN1350546A (de)
AT (1) ATE445638T1 (de)
AU (1) AU6480999A (de)
BR (1) BR9915055A (de)
CA (1) CA2348475A1 (de)
DE (1) DE69941545D1 (de)
DK (1) DK1144447T3 (de)
ES (1) ES2333073T3 (de)
ID (1) ID29858A (de)
MX (1) MXPA01004469A (de)
WO (1) WO2000026248A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624456D0 (en) * 1996-11-25 1997-01-15 Isis Innovation Assay method
DK1144447T3 (da) * 1998-11-04 2010-02-08 Isis Innovation Dianostisk tuberkulosetest
NZ526807A (en) 2001-01-08 2005-03-24 Isis Innovation Assay to determine efficacy of treatment for mycobacterial infection
GB0215710D0 (en) * 2002-07-05 2002-08-14 Isis Innovation Diagnostic method
EP1716417B1 (de) * 2004-02-19 2008-03-05 Department Of Biotechnology, Ministery Of Science And Technology, Government Of India Diagnostischer kit zum nachweis pulmonaler und extrapulmonaler tb
ITRM20040091A1 (it) 2004-02-19 2004-05-19 Istituto Naz Per Le Malattie Test immunologico rapido per la diagnosi ed il monitoraggio dell'infezione tubercolare.
CN1305900C (zh) * 2004-03-16 2007-03-21 中国药品生物制品检定所 Esat－6蛋白在诊断结核病中的用途
GB0406271D0 (en) 2004-03-19 2004-04-21 Isis Innovation Diagnostic test
FR2872579B1 (fr) * 2004-06-30 2006-11-24 Pasteur Institut Detection de la tuberculose et de l'infection par mycobacterium tuberculosis a l'aide de hbha
CA2616766A1 (en) * 2005-07-26 2007-02-01 University Of Medicine And Dentistry Of New Jersey Antibody profiles characteristic of tuberculosis state
CN101294964B (zh) * 2007-11-27 2012-06-27 复旦大学附属华山医院 一种检测活动性结核病和结核潜伏感染的试剂和方法
CN102297968B (zh) * 2010-06-28 2013-10-30 程小星 辅助诊断结核病的试剂盒
ITRM20100411A1 (it) * 2010-07-23 2012-01-24 Massimo Amicosante Uso di sequenze amminoacidiche da mycobacterium tuberculosis o dei loro corrispondenti acidi nucleici per la diagnosi e la prevenzione di infezione tubercolare, relativo kit diagnostico e vaccino.
CN101985473B (zh) * 2010-10-12 2011-11-09 浙江大学 抗结核杆菌esat-6单克隆抗体tbef3及应用
CN101987872B (zh) * 2010-10-12 2011-11-09 浙江大学 抗结核杆菌esat-6单克隆抗体tbea8及应用
IT1403092B1 (it) 2010-12-01 2013-10-04 Univ Degli Studi Modena E Reggio Emilia Metodo per la diagnosi e/o il monitoraggio della mucormicosi.
CN102305855A (zh) * 2011-05-19 2012-01-04 中山大学 体外检测结核分枝杆菌感染的试剂和方法
EP4556906A3 (de) 2011-06-29 2025-08-06 QIAGEN Australia Holding Pty. Ltd. Zellvermittelter immunreaktionstest mit erhöhter empfindlichkeit
MX347154B (es) 2012-02-24 2017-02-21 Centro De Investigación Científica Y De Educación Superior De Ensenada Baja California (Cicese) Prueba de diagnóstico para enfermedades infecciosas en ganado bovino.
RU2571713C2 (ru) * 2014-05-12 2015-12-20 Федеральное Государственное Бюджетное Учреждение "Новосибирский научно-исследовательский институт туберкулеза" Минздрава России (ФГБУ "ННИИТ" Минздрава России) Способ диагностики латентного туберкулеза внелегочных локализаций
CN105954521B (zh) * 2016-07-08 2017-04-12 广州华弘生物科技有限公司 一种结核分枝杆菌感染诊断试剂盒
US10245320B2 (en) 2016-09-30 2019-04-02 Enzo Biochem, Inc. Immunomodulatory pharmaceutical compositions and methods of use thereof
US10684275B2 (en) 2016-12-14 2020-06-16 Becton, Dickinson And Company Methods and compositions for obtaining a tuberculosis assessment in a subject
EP3399312A1 (de) * 2017-05-05 2018-11-07 Biomérieux Erkennungsverfahren einer zellulären immunantwort
EP3619533B1 (de) 2017-05-05 2022-09-28 bioMérieux Erkennungsverfahren einer zellulären immunantwort
WO2019018607A1 (en) 2017-07-20 2019-01-24 Enzo Biochem, Inc. IMMUNOMODULATORY COMPOSITIONS AND METHODS OF USE THEREOF
BR112023006262A2 (pt) 2020-10-06 2023-05-09 Cepheid Métodos de diagnóstico de tuberculose e de diferenciação entre tuberculose ativa e latente

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955077A (en) * 1993-07-02 1999-09-21 Statens Seruminstitut Tuberculosis vaccine
DK79893D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine
US6641814B1 (en) * 1997-04-02 2003-11-04 Statens Serum Institut Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis
US6991797B2 (en) * 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US5736524A (en) * 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5775870A (en) * 1995-08-03 1998-07-07 Hogan; Sherman David Vehicle side tilting apparatus
US6592877B1 (en) * 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6290969B1 (en) * 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
AU727602B2 (en) * 1995-09-01 2000-12-14 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) * 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6338852B1 (en) * 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6087163A (en) * 1997-02-06 2000-07-11 The Public Health Research Institute Of The City Of New York, Inc. Mycobacterium tuberculosis specific proteins and genes, mixtures of anitgens and uses thereof
GB9624456D0 (en) * 1996-11-25 1997-01-15 Isis Innovation Assay method
US6245331B1 (en) * 1997-01-02 2001-06-12 New York Univ. Medical Center Early detection of mycobacterial disease
US6350456B1 (en) * 1997-03-13 2002-02-26 Corixa Corporation Compositions and methods for the prevention and treatment of M. tuberculosis infection
US6982085B2 (en) * 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en) * 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
US6613881B1 (en) * 1997-05-20 2003-09-02 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
EP0902086A1 (de) * 1997-08-22 1999-03-17 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Tuberkolose Impfstoff
WO1999045119A2 (en) * 1998-03-06 1999-09-10 Statens Serum Institut Production of mycobacterial polypeptides by lactic acid bacteria
PL202844B1 (pl) * 1998-04-07 2009-07-31 Corixa Corp Immunogeniczny polipeptyd, polinukleotyd, polipeptyd, kompozycja farmaceutyczna, wektor ekspresji, kompozycja szczepionki, polipeptyd do stosowania w leczeniu lub zapobieganiu infekcjom Mycobacterium tuberculosis, polinukleotyd do stosowania w leczeniu lub zapobieganiu infekcjom Mycobacterium tuberculosis i sposób wytwarzania polipeptydu
US20030044431A1 (en) * 1998-06-19 2003-03-06 Gerhardt Schurig Over-expressing homologous antigen vaccine and a method of making the same
DK1144447T3 (da) * 1998-11-04 2010-02-08 Isis Innovation Dianostisk tuberkulosetest
US20020131976A1 (en) * 1998-12-23 2002-09-19 Ajit Lalvani Tuberculosis vaccine
US6649170B1 (en) * 1999-05-12 2003-11-18 Statens Serum Institut Adjuvant combinations for immunization composition and vaccines
JP5010079B2 (ja) * 1999-07-13 2012-08-29 スタテンズ セーラム インスティテュート マイコバクテリウム・ツベルクローシスｅｓａｔ−６遺伝子ファミリーベースの結核ワクチン及び診断法
US6537552B1 (en) * 1999-10-19 2003-03-25 Iowa State University Research Foundation Vaccine adjuvant
US6776993B2 (en) * 2000-02-22 2004-08-17 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Tuberculosis vaccine
AU2001241738A1 (en) * 2000-02-25 2001-09-03 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
ATE318465T1 (de) 2000-08-11 2006-03-15 Koninkl Philips Electronics Nv Verfahren und anordnung zur synchronisierung eines sigma-delta-modulators
NZ526807A (en) * 2001-01-08 2005-03-24 Isis Innovation Assay to determine efficacy of treatment for mycobacterial infection
WO2003000721A2 (en) * 2001-06-22 2003-01-03 Health Protection Agency Mycobacterial antigens expressed under low oxygen tension
FR2828934B1 (fr) * 2001-08-27 2004-08-13 Inst Nat Sante Rech Med Test de l'immunite cellulaire par des peptides fixes sur support solide
GB0125535D0 (en) * 2001-10-24 2001-12-12 Microbiological Res Authority Mycobacterial genes down-regulated during latency
GB0215710D0 (en) * 2002-07-05 2002-08-14 Isis Innovation Diagnostic method
WO2004099771A1 (en) * 2003-05-08 2004-11-18 Statens Serum Institut A new specific epitope based immunological diagnosis of tuberculosis
WO2005054851A1 (en) * 2003-11-21 2005-06-16 Institut Pasteur Recombinant adenylate cyclase of bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase
ITRM20040091A1 (it) * 2004-02-19 2004-05-19 Istituto Naz Per Le Malattie Test immunologico rapido per la diagnosi ed il monitoraggio dell'infezione tubercolare.
GB0406271D0 (en) * 2004-03-19 2004-04-21 Isis Innovation Diagnostic test
US7820142B2 (en) * 2004-09-30 2010-10-26 Institut Pasteur Immunogenic glycopeptides, screening, preparation and uses
GB0500102D0 (en) * 2005-01-05 2005-02-09 Isis Innovation Method for generating a memory t cell response
US20080124738A1 (en) * 2005-03-01 2008-05-29 Pritest, Inc Compositions and methods of testing for tuberculosis and mycobacterium infection
AU2006229549B2 (en) * 2005-03-31 2011-04-07 Leiden University Medical Center Methods and means for diagnostics, prevention and treatment of Mycobacterium infections and tuberculosis disease
EP1910410B1 (de) * 2005-07-01 2011-10-26 Forsyth Dental Infirmary for Children Assays zum nachweis von tuberkulose- antigenen, und impfstoffe
CA2616766A1 (en) * 2005-07-26 2007-02-01 University Of Medicine And Dentistry Of New Jersey Antibody profiles characteristic of tuberculosis state
GB0605474D0 (en) * 2006-03-17 2006-04-26 Isis Innovation Clinical correlates
EP2040745B1 (de) * 2006-06-28 2012-12-05 Statens Serum Institut Expansion des t-zell-repertoirs, um subdominante epitope durch impfung mit antigenen, die als proteinfragmente oder peptidcocktails abgegeben werden, aufzunehmen
GB0618127D0 (en) * 2006-09-14 2006-10-25 Isis Innovation Biomarker
DE112007003312B4 (de) * 2007-01-31 2019-02-07 Council Of Scientific & Industrial Research Verfahren zur Verbindung oxidischer supraleitender Rohre mit einer supraleitenden Verbindungsstelle
GB0708874D0 (en) * 2007-05-08 2007-06-13 Univ The Of Birmingham Assay for detecting mycrobacterial infection
US8071561B2 (en) * 2007-08-16 2011-12-06 Chrontech Pharma Ab Immunogen platform
US10611818B2 (en) * 2007-09-27 2020-04-07 Agilent Technologies, Inc. MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
GB0722105D0 (en) * 2007-11-10 2007-12-19 Sec Dep For Environment Food A Antigens
US7670609B2 (en) * 2007-11-27 2010-03-02 Aeras Global Tb Vaccine Foundation Recombinant BCG tuberculosis vaccine designed to elicit immune responses to Mycobacterium tuberculosis in all physiological stages of infection and disease
AU2009273130B2 (en) * 2008-07-25 2014-10-16 Glaxo Group Limited Novel compositions and methods
JP2012503206A (ja) * 2008-09-22 2012-02-02 オレゴン ヘルス アンド サイエンス ユニバーシティ Ｍｙｃｏｂａｃｔｅｒｉｕｍｔｕｂｅｒｃｕｌｏｓｉｓ感染を検出するための方法
US20100159485A1 (en) * 2008-12-19 2010-06-24 Centre For Dna Fingerprinting And Diagnostics Detection of mycobacterium tuberculosis
GB0906215D0 (en) * 2009-04-09 2009-05-20 Lalvani Ajit Diagnostic test
CN102713629B (zh) * 2009-11-20 2016-02-24 俄勒冈健康科学大学 用于检测结核分枝杆菌感染的方法

Also Published As

Publication number Publication date
US8507211B2 (en) 2013-08-13
US9005902B2 (en) 2015-04-14
EP1144447A2 (de) 2001-10-17
ES2333073T3 (es) 2010-02-16
US20100041075A1 (en) 2010-02-18
DE69941545D1 (de) 2009-11-26
US20110201044A1 (en) 2011-08-18
ATE445638T1 (de) 2009-10-15
US20130310271A1 (en) 2013-11-21
AU6480999A (en) 2000-05-22
BR9915055A (pt) 2001-08-07
US7901898B2 (en) 2011-03-08
US7632646B1 (en) 2009-12-15
JP2002532064A (ja) 2002-10-02
WO2000026248A2 (en) 2000-05-11
US20120264141A1 (en) 2012-10-18
US8216795B2 (en) 2012-07-10
EP1144447B1 (de) 2009-10-14
JP4633931B2 (ja) 2011-02-16
MXPA01004469A (es) 2002-08-30
CA2348475A1 (en) 2000-05-11
DK1144447T3 (da) 2010-02-08
WO2000026248A3 (en) 2001-10-11
CN1350546A (zh) 2002-05-22

Similar Documents

Publication Publication Date Title
ID29858A (id) Uji diagnostik tuberkulosis
DE60026332D1 (de) Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen
ATE213068T1 (de) Testverfahren für peptidspezifische t-zellen
TR200000113T2 (tr) Tüberkülozu teşhis etmek için bileşikler ve bunları kullanma yöntemleri.
DK1092155T3 (da) Fremgangsmåde til tidlig diagnose af carcinomer
DE69421617D1 (de) Homogene immunoassays unter verwendung von mutanten glucose-6-phosphatdehydrogenasen
NZ514887A (en) IBD-associated microbial antigens and methods of using same
TR199901569T2 (xx) T�berk�lozun te�hisi i�in bile�ikler ve y�ntemler.
AU7652194A (en) A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
EP1571160A4 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
JP2002532064A5 (de)
EP2060631A3 (de) Charakterisierung granulocytischer Ehrlichien und Verfahren zu ihrer Anwendung
MX9602495A (es) Peptidos novedosos derivados de autoantigeno para usarse en inmunoterapia de enfermedades autoinmunes.
EP1950221A3 (de) Genomsequenzen von exportierten Polypeptiden aus Mykobakterien, diese enthaltende Vektoren und deren Anwendung in der Diagnostik und Prävention von Tuberkulose
DE69638024D1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
ATE499610T1 (de) Verfahren zur diagnostik von tuberkulose
KR950008537A (ko) 엡스타인 바 비루스(ebv)에 대한 항체의 검출용 진단제
ATE363070T1 (de) Auswertung von biologischen mitteln in lebenden zielzellen
EP1132402A4 (de) Peptidfragmente mit den zelltod verhindernden aktivität
DE68927635D1 (de) Igm-antikörper gegen protamin
EP2071338A3 (de) Menschliche Diabetes-vermittelnde Proteine
Yaoi et al. N-and C-Terminal Residues in Baker's Yeast Cytochrome c
FR2828934B1 (fr) Test de l'immunite cellulaire par des peptides fixes sur support solide
FR2663034B1 (fr) Peptides de l'antigene sm-d et leur utilisation notamment pour le diagnostic du lupus erythemateux dissemine.
Meliconi et al. Antibodies to topoisomerase II in idiopathic pulmonary fibrosis